Capital Performance Advisors »

Century Therapeutics shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $21 12 1.75

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Century Therapeutics

VR Adviser
Boxer Capital
Casdin Capital
BlackRock
DAFNA Capital Management
Geode Capital Management
Tang Capital Management
Baker Bros. Advisors
Octagon Capital Advisors
Renaissance Technologies
Charles Schwab Investment Management
Northern Trust
Acadian Asset Management
Bank of New York Mellon
Jpmorgan Chase & Co

View all funds holding Century Therapeutics